Low clinical adoption of tumor genomic profiling: cause for concern?
作者信息
Drazer Michael W, Sweis Randy F
机构信息
a Department of Medicine, Section of Hematology/Oncology , Comprehensive Cancer Center, University of Chicago , IL , USA.
b Department of Human Genetics , University of Chicago , IL , USA.
出版信息
J Med Econ. 2018 Jul;21(7):721-723. doi: 10.1080/13696998.2018.1470978. Epub 2018 May 15.
Abstract
摘要
相似文献
1
Low clinical adoption of tumor genomic profiling: cause for concern?肿瘤基因组分析在临床中的低采用率：值得担忧吗？
J Med Econ. 2018 Jul;21(7):721-723. doi: 10.1080/13696998.2018.1470978. Epub 2018 May 15.
2
Fidelity and deceit at the bedside.
JAMA. 2000 Apr 12;283(14):1881-4. doi: 10.1001/jama.283.14.1881.
3
Precision Medicine.精准医学
Health Aff (Millwood). 2018 May;37(5):687. doi: 10.1377/hlthaff.2018.0520.
4
Ideal and Reality: The Gap Between Evidence Derived From Randomized Controlled Trial-Based Meta-analysis and Real-World Clinical Practice in Antidepressant Strategy for Depression.理想与现实：基于随机对照试验的荟萃分析所得证据与抑郁症抗抑郁策略的真实世界临床实践之间的差距
J Clin Psychopharmacol. 2020 Jul/Aug;40(4):428-429. doi: 10.1097/JCP.0000000000001231.
5
Diffusion and Use of Tethered Personal Health Records in Primary Care.初级保健中绑定式个人健康记录的传播与应用
Perspect Health Inf Manag. 2015 Apr 1;12(Spring):1c. eCollection 2015.
6
The dangers of incorporating reimbursement data into clinical decision making.
Pract Radiat Oncol. 2015 Jul-Aug;5(4):274-6. doi: 10.1016/j.prro.2015.01.002. Epub 2015 Feb 18.
7
Physician manipulation of reimbursement rules for patients: between a rock and a hard place.医生对患者报销规则的操控：进退两难。
JAMA. 2000 Apr 12;283(14):1858-65. doi: 10.1001/jama.283.14.1858.
8
Changes in prescription pattern, pharmaceutical expenditure and quality of care after introduction of reimbursement restriction in diabetes in Korea.韩国引入糖尿病报销限制后处方模式、药品支出和医疗质量的变化。
Eur J Public Health. 2018 Apr 1;28(2):209-214. doi: 10.1093/eurpub/ckx168.
9
Physicians. Profiling in practice.医生。实践中的剖析。
Hosp Health Netw. 1994 Jan 20;68(2):50-1.
10
Low-Value Health Care Services in a Commercially Insured Population.商业保险人群中的低价值医疗服务
JAMA Intern Med. 2016 Oct 1;176(10):1567-1571. doi: 10.1001/jamainternmed.2016.5031.
本文引用的文献
1
Real-world utilization of molecular diagnostic testing and matched drug therapies in the treatment of metastatic cancers.分子诊断检测与匹配药物疗法在转移性癌症治疗中的真实世界应用。
J Med Econ. 2018 Jun;21(6):543-552. doi: 10.1080/13696998.2017.1423488. Epub 2018 Jan 19.
2
Cancer Drugs Approved Based on Biomarkers and Not Tumor Type-FDA Approval of Pembrolizumab for Mismatch Repair-Deficient Solid Cancers.基于生物标志物而非肿瘤类型获批的癌症药物——美国食品药品监督管理局批准帕博利珠单抗用于错配修复缺陷实体癌
JAMA Oncol. 2018 Feb 1;4(2):157-158. doi: 10.1001/jamaoncol.2017.4182.
3
Patient-Paired Sample Congruence Between 2 Commercial Liquid Biopsy Tests.患者配对样本在 2 种商业液体活检检测中的一致性。
JAMA Oncol. 2018 Jun 1;4(6):868-870. doi: 10.1001/jamaoncol.2017.4027.
4
First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication.美国食品药品监督管理局首次批准与癌症部位无关——当生物标志物确定适应症时。
N Engl J Med. 2017 Oct 12;377(15):1409-1412. doi: 10.1056/NEJMp1709968.
5
Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer.用于转移性结直肠癌的表皮生长因子受体（EGFR）抑制剂
Cochrane Database Syst Rev. 2017 Jun 27;6(6):CD007047. doi: 10.1002/14651858.CD007047.pub2.
6
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.从10000例患者的前瞻性临床测序中揭示的转移性癌症的突变图谱。
Nat Med. 2017 Jun;23(6):703-713. doi: 10.1038/nm.4333. Epub 2017 May 8.
7
Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate.《平价医疗法案》强制实施后癌症临床试验参与的保险拒赔情况。
Cancer. 2017 Aug 1;123(15):2893-2900. doi: 10.1002/cncr.30689. Epub 2017 Mar 23.
8
Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement.临床试验特征与受试者招募障碍：MD安德森癌症中心30年的经验，试验改进的历史基础
Clin Cancer Res. 2017 Mar 15;23(6):1414-1421. doi: 10.1158/1078-0432.CCR-16-2439. Epub 2017 Mar 8.
9
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.《结肠癌临床实践指南（2017 年版）》，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2017 Mar;15(3):370-398. doi: 10.6004/jnccn.2017.0036.
10
Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center: Identification of Targetable Variants and Experience with Reimbursement.大型学术癌症中心多种肿瘤标本的临床基因组分析：可靶向变异的鉴定及报销经验
J Mol Diagn. 2017 Mar;19(2):277-287. doi: 10.1016/j.jmoldx.2016.10.008. Epub 2016 Dec 23.
Zotero 插件